Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?

Erez N. Baruch; Tanmay Gaglani; Jennifer A. Wargo

doi:10.1177/17588359211045853

Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?

Erez N. Baruch, Tanmay Gaglani, Jennifer A. Wargo

Surgical Oncology

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Original language	English (US)
Journal	Therapeutic Advances in Medical Oncology
Volume	13
DOIs	https://doi.org/10.1177/17588359211045853
State	Published - 2021

Keywords

anti-PD-1
checkpoint inhibitors
fecal microbiota transplantation
immunotherapy
melanoma
microbiome

ASJC Scopus subject areas

Oncology

Access to Document

10.1177/17588359211045853

Cite this

@article{6726567aae2149e6a38daf5667c107b5,

title = "Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?",

keywords = "anti-PD-1, checkpoint inhibitors, fecal microbiota transplantation, immunotherapy, melanoma, microbiome",

author = "Baruch, {Erez N.} and Tanmay Gaglani and Wargo, {Jennifer A.}",

note = "Funding Information: J.A.W. is supported by NIH (1 R01 CA219896-01A1), Melanoma Research Alliance (4022024), American Association for Cancer Research Stand Up To Cancer (SU2C-AACR-IRG-19-17), and MD Anderson Cancer Center{\textquoteright}s Melanoma Moon Shots Program. ",

year = "2021",

doi = "10.1177/17588359211045853",

language = "English (US)",

volume = "13",

journal = "Therapeutic Advances in Medical Oncology",